Rina Rosenzweig

Dr. Rosenzweig received a BSc in Chemistry and PhD in Biochemistry from the Technion - Israel Institute of Technology, followed by postdoctoral studies at the University of Toronto. In her lab, she uses advanced NMR techniques, as well as biophysical and biochemical approaches to study the structure, dynamics, and interactions of large protein assemblies. Her group seeks to explore how these complex systems operate and use this knowledge to better understand the causes behind a host of neurodegenerative disorders related to protein misfolding and aggregation. She has received several honors and awards, including the Hestrin Prize for Excellence in Biochemical Research from The Israel Society for Biochemistry and Molecular Biology (2021), the Russell Varian Young Investigator International Award in Magnetic Resonance (2022), and most recently the Blavatnik Award (2023) for discovering the regulatory mechanism by which chaperone proteins drive the innate ability of our cells to prevent and reverse protein aggregation.